1. Home
  2. OLMA vs REFI Comparison

OLMA vs REFI Comparison

Compare OLMA & REFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • REFI
  • Stock Information
  • Founded
  • OLMA 2006
  • REFI 2021
  • Country
  • OLMA United States
  • REFI United States
  • Employees
  • OLMA N/A
  • REFI N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • REFI Real Estate Investment Trusts
  • Sector
  • OLMA Health Care
  • REFI Real Estate
  • Exchange
  • OLMA Nasdaq
  • REFI Nasdaq
  • Market Cap
  • OLMA 383.1M
  • REFI 314.2M
  • IPO Year
  • OLMA 2020
  • REFI 2021
  • Fundamental
  • Price
  • OLMA $4.99
  • REFI $15.55
  • Analyst Decision
  • OLMA Strong Buy
  • REFI Strong Buy
  • Analyst Count
  • OLMA 4
  • REFI 3
  • Target Price
  • OLMA $28.33
  • REFI $20.00
  • AVG Volume (30 Days)
  • OLMA 1.0M
  • REFI 170.0K
  • Earning Date
  • OLMA 03-10-2025
  • REFI 03-11-2025
  • Dividend Yield
  • OLMA N/A
  • REFI 16.72%
  • EPS Growth
  • OLMA N/A
  • REFI N/A
  • EPS
  • OLMA N/A
  • REFI 2.00
  • Revenue
  • OLMA N/A
  • REFI $56,860,278.00
  • Revenue This Year
  • OLMA N/A
  • REFI N/A
  • Revenue Next Year
  • OLMA N/A
  • REFI $6.40
  • P/E Ratio
  • OLMA N/A
  • REFI $7.78
  • Revenue Growth
  • OLMA N/A
  • REFI 6.49
  • 52 Week Low
  • OLMA $4.60
  • REFI $14.82
  • 52 Week High
  • OLMA $16.62
  • REFI $16.49
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 38.98
  • REFI 46.54
  • Support Level
  • OLMA $4.94
  • REFI $15.93
  • Resistance Level
  • OLMA $5.34
  • REFI $16.07
  • Average True Range (ATR)
  • OLMA 0.42
  • REFI 0.21
  • MACD
  • OLMA -0.03
  • REFI 0.04
  • Stochastic Oscillator
  • OLMA 11.39
  • REFI 43.48

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About REFI Chicago Atlantic Real Estate Finance Inc.

Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.

Share on Social Networks: